Rat placental lactogen-I (rPL-I), the first prolactin-like hormone expressed in the placenta during pregnancy in the rat, is known to influence maternal functions. In the present study, we have investigated the effects of rPL-I on the growth and development of cultured whole rat embryos. Rat embryos, with or without ectoplacental cone (EPC) attached, were explanted at day 9 of gestation. After 48 h of culture, the embryos, enclosed by the yolk sacs, were assessed by the presence of visible heart contractions ('heart beats'), crown-rump length (CRL) and yolk sac diameter (YSD). When intact embryos with EPC were cultured, the concentrations of rPL-I and rPL-II (products of EPC) in the medium were 850 841 and 92 181 ng/ml respectively (means ...). In embryo cultures with the EPC removed, rPL-I levels decreased toc10 ng/ml, and only 70% of the embryos were viable, with visible heart beats. In the viable embryos, both CRL and embryonic DNA synthesis were reduced compared with controls, and the addition of rPL-I (1 µg/ml) did not prevent this reduction. YSD and yolk sac DNA synthesis were also reduced compared with control embryos, and the addition of rPL-I significantly prevented this decrease by 45%. In embryos cultured without EPC in the presence of neutralizing rabbit anti-rat prolactin serum (anti-rPRL), embryonic and yolk sac DNA synthesis were reduced by 35% compared with embryos exposed to normal rabbit serum. Addition of rPL-I significantly increased (P<0·05) embryonic and yolk sac growth. Thus the effects of rPL-I on embryo growth could only be seen in the absence of prolactin. The addition of human prolactin in the presence of anti-rPRL also resulted in significant increases (P<0·05) in embryonic DNA synthesis and CRL. These results suggest that rPL-I may substitute for prolactin to influence the growth of the rat embryo.
Introduction
In oviparous species, regulatory factors contained in the egg play a critical role in the development of the embryo. Mammalian embryonic development, however, is dependent on regulatory factors produced by maternal, embryonic and extraembryonic tissues. Successful maturation of mammalian embryos and fetuses requires the proper functioning of the placenta, a specialized extraembryonic tissue of pregnancy. The placenta produces a number of regulatory factors including placental lactogens (PLs), which are similar in amino acid sequence to the prolactin (PRL) of the anterior pituitary (Friesen et al. 1993) .
Although PLs in the rat have been shown to have PRL-like functions in the mother (Bridges et al. 1996 (Bridges et al. , 1997 , very little is known about their biological significance in the embryo/fetus. Receptor sites for PLs are present in maternal decidua at mid gestation and in fetal tissues (Freemark et al. 1993) . In the rat, two PLs are produced, rPL-I on days 8-13 of gestation (organogenesis period) and rPL-II on days 13 to term (period of rapid growth and tissue differentiation) (Friesen et al. 1993) . Moreover, PLs may be involved in the regulation of the synthesis of insulin-like growth factors-I and -II in the fetus (Lassarre et al. 1991) . Targeted gene disruption studies have clearly shown that these growth factors are essential for embryonic and postnatal growth in mice (Baker et al. 1993) .
The objective of this investigation was to study the effect of rPL-I on whole rat embryos in culture. The results show that rPL-I stimulated the growth and development of the rat embryo/fetus.
Materials and Methods
Mating of animals and preparation of serum and culture medium mature males, and the day on which spermatozoa were found in the vaginal smear was considered day zero of gestation.
Blood was collected from anesthetized male SpragueDawley rats by inserting a 21 gauge needle at the bifurcation of the abdominal aorta. The separated serum, to be used for culturing the embryos, was then transferred into 4·5 ml tubes and stored at 20 C. When required, the serum was heat inactivated (at 56 C for 30 min) to destroy complement and filtered using sterile micro filters (Millipore, Bedford, MA, USA; 0·45 µm). The culture medium (75% rat serum and 25% Dulbecco's modified Eagles' medium) was transferred to 30 ml (Wheaton Scientific, Millville, NJ, USA) culture bottles (4 ml medium/bottle). The level of rat PRL (rPRL) in the culture medium, determined by RIA, was 44 30 ng/ml for a total of approximately 176 ng per culture; this rPRL was derived from the normal rat serum used in the culture medium. A premixed combination of penicillin/ streptomycin was added to a dose of 50 IU/ml and 50 µg/ml of medium respectively.
Embryo culture
Whole rat embryos were cultured by established methods (Brown et al. 1979 , Seyoum & Persaud 1994 . On day 9 of gestation, pregnant animals were anesthetized with ether, and the gravid uterus was excised and placed in a Petri dish containing Hanks balanced salt solution. The uterine horns were incised along the anti-mesometrial border. With the help of a cataract knife and a dissecting microscope, the decidual swellings were explanted from the uterus. Each decidual swelling was then split open into two halves by using two pairs of fine forceps (Type 5 Dumont forceps, Fine Science Tools Inc, Vancouver, BC, Canada) and one of the two halves contained the embryo. The embryo, enclosed in its membranes, was gently eased from the decidua. Reichert's membrane was completely opened and removed. The embryos were now ready for culturing. The ectoplacental cone (EPC) was either left intact or removed from the embryo before culture.
Embryos were randomly placed (four/bottle) in the respective treatment groups. After gassing (see below), the culture bottles containing the embryos were then placed on a roller bottle platform rotating at 35 r.p.m. in a 39 C incubator. In order to minimize intergroup variability due to maternal factors, embryos from one pregnant animal were equally distributed among treatment groups within a given experiment.
Embryos were gassed with varying concentrations of oxygen at three intervals. The first gas phase of 5% O 2 /5% CO 2 /90% N 2 was used immediately after the embryos had been placed in the culture bottles and lasted for the first 18 h of incubation. The second gas phase of 20% O 2 /5% CO 2 /75% N 2 was then used for the next 8 h. For the third phase, embryos were gassed with 40% O 2 /5% CO 2 /55% N 2 for the remaining 22 h of the culture period. At the end of the 48 h culture period, the viability of the embryos was determined by the presence of contractions of the visible heart. Only viable embryos with visible heart beats were included in the analysis.
Measurements and analysis
Crown-rump length (CRL) and yolk sac diameter (YSD) of the embryos were measured by using a dissecting microscope equipped with an ocular grid with 0·1 mm scale markers. DNA synthesis in the embryo and yolk sac was determined by the [ 3 H]thymidine-uptake assay. [ 3 H]Thymidine (7 µCi/ml) was added to the culture medium at 26 h. The experiment was terminated at 48 h and YSD and CRL were measured. Individual yolk sacs and embryos were collected in 10% trichloroacetic acid, and the trichloroacetate-precipitated DNA was determined. Statistical analysis of the data was performed using ANOVA (Sigma Stat; Jandel Scientific, SPSS Inc, Chicago, IL, USA) and a probability level of P<0·05 was considered significant.
Established homologous RIAs for rPL-I and rPL-II were used to estimate the levels of these hormones in the culture medium (Robertson & Friesen 1981 , Robertson et al. 1994 . In samples in which antibodies had been added to the culture medium, it was not possible to use RIA to determine the amount of hormone. Therefore the level of rPL-I present in the medium was estimated by the Nb2 lymphoma cell bioassay, which measures the mitogenic activity of lactogenic hormones. The Nb2 lymphoma cell bioassay was carried out as described by Tanaka et al. (1980) with minor modifications noted by Robertson et al. (1994) ; the intra-and inter-assay variations were 3 and 5% respectively. Recombinant rPL-I was used as standard and antibodies to rPRL (final dilution 1:2000) were added to Fischer's medium to neutralize any rPRL present in the samples.
Preparation of recombinant rPL-I and antiserum
Affinity-purified recombinant rPL-I protein was produced as described by Robertson et al. (1994) . Neutralizing antibodies to rPL-I were generated in rabbits as described by Robertson et al. (1994) , and they are specific for rPL-I (Robertson et al. 1994) . Antibodies to rPRL were generated by a similar regimen using purified rPRL (NIH, Bethesda, MD, USA) as the immunogen, and they are specific for rPRL as they show no cross-reactivity with rPL-I, rPL-II or other rat pituitary hormones (Bridges et al. 1996) .
Purified immunoglobulins were isolated from antisera to rPL-I by applying 15 ml anti-rPL-I diluted with 30 ml 0·1 M sodium phosphate buffer (pH 8·0) to a Protein A column. After the gel had been washed with approximately 10 volumes of 0·1 M sodium phosphate buffer (pH 8·0), the IgG molecules were eluted with 0·1 M citrate (pH 3·0). The pooled IgG fractions were dialyzed against PBS and concentrated with a Centriprep-10 concentrator (Amicon, Beverly, MA, USA) to approximately 7 ml. The purified -globulins were filtered using micro filters (Millipore; 0·45 µm), and the protein content was estimated by the Bradford (1976) method using rabbit -globulin as standard. To serve as controls, -globulins from 15 ml normal male rabbit serum were purified on the regenerated Protein A affinity column using the above procedure.
Treatment of whole rat embryos in culture
The first series of experiments (see Table 2 ) were designed to investigate the effects of the addition of exogenous rPL-I or the removal of endogenous rPL-I by the addition of its antibodies on embryonic growth and development. Embryos with intact EPC were placed in medium containing either 2 mg/ml affinity-purified non-immune immunoglobulins (control group) or 2 mg/ml affinitypurified neutralizing antibodies to rPL-I (anti-rPL-I group) or 1 µg/ml purified rPL-I (rPL-I group). At the end of the 48 h incubation period, CRL and YSD were measured.
In experiments designed to investigate the influence of removal of the EPC from the embryo on embryonic growth and development (see Table 3 ), embryos were explanted from the uterus (on day 9 of gestation) and the EPC was carefully detached and removed from the embryo. Embryos were cultured in the presence or absence of exogenous rPL-I (1 µg/ml; 40 nM). The control group contained an intact EPC. After 25 h, [ 3 H]thymidine was added. At the end of the 48 h incubation period, embryonic DNA synthesis and CRL, as well as yolk sac DNA synthesis and YSD, were measured.
In experiments designed to study the effect of rPL-I on embryonic growth and development in the absence of rPRL (see Tables 4 and 5 ), embryos devoid of EPC were cultured in the presence of either 100 µl normal rabbit serum or rabbit anti-rPRL serum. This amount of rabbit anti-rPRL serum has a maximum capacity to neutralize 500 ng rPRL assessed separately by the Nb2 lymphoma cell assay; however, the total amount of rabbit serum protein contributed to the culture medium was negligible since the latter contained 75% (v/v) normal rat serum. Some cultures also received 1 µg/ml rPL-I (Table 4) or human PRL (Table 5 ). DNA synthesis, CRL and YSD were determined as described in the previous section.
Results
Previous studies (Brown et al. 1979 , Seyoum & Persaud 1994 have demonstrated that the preservation of the EPC in rat embryos explanted on day 9 was required for optimal embryonic growth and development in culture. In vivo, the EPC eventually develops into the mature fetal placenta. In the present study, specific RIAs revealed that both rPL-I and rPL-II are produced by the EPC and accumulate in the culture medium. Over the 48 h culture period, the concentration of rPL-I in the culture medium was 850 84 ng/ml (Table 1) . The concentration of rPL-I was 10 times higher than that of rPL-II (92 18 ng/ml) accumulated over the same period.
The role of rPL-I in the growth and development of embryos in culture was first investigated by administering neutralizing antibodies to rPL-I or by adding rPL-I to the culture medium. The addition of neither exogenous rPL-I nor anti-rPL-I antibodies to the culture medium changed embryonic growth beyond control values ( Table 2 ). The failure to influence embryo growth and development by these conditions was probably due to the already high levels of rPL-I produced by the embryo in culture. Moreover, an Nb2 lymphoma cell assay performed on the culture medium revealed that the addition of anti-rPL-I serum only partially neutralized rPL-I, leaving a significant level of 40% lactogenic hormones, consisting mostly of rPL-I as well as rPL-II and rPRL (from rat serum) (Table 1) . Rat embryos cultured with an intact EPC had a viability (with visible heart beats) of greater than 95%.
In order to confirm that the EPC of the embryo was the source of rPL-I, embryos were cultured without the EPC. In embryos cultured without the EPC, embryo viability was 70%. Removal of the EPC from embryos almost completely stopped the production of rPL-I ( Table 1 ). The concentration of rPL-I in the culture medium of embryos devoid of EPC was 10 3 ng/ml which was only about 1% of the control value (Table 1) . Therefore, in order to investigate whether or not exogenously added rPL-I could substitute for the EPC, embryos devoid of EPC were cultured in the presence or absence of added rPL-I. The addition of rPL-I (1 µg/ml) significantly increased (P<0·05) yolk sac DNA synthesis and YSD (Table  3) . However, exogenous rPL-I failed to alter embryo viability, embryonic DNA synthesis and CRL. The embryos cultured in the absence of rPL-I were noticeably abnormal, as reflected in embryo body flexion: some were dorsiflexed (Fig. 1) . The addition of rPL-I corrected this dorsiflexion in many embryos. Embryos cultured with or without EPC and in the presence or absence of exogenous rPL-I are shown in Fig. 1 . To examine whether the rPRL in the culture medium could have masked the effect of rPL-I on embryo growth, we next studied the effect of removing PRL from the culture medium on embryonic growth using the same 'minus EPC model'. PRL was removed from the medium by using anti-rPRL antibodies, and embryos were cultured again in the presence or absence of exogenous rPL-I. When PRL was neutralized, the addition of rPL-I significantly increased (P<0·05) both embryonic and yolk sac DNA synthesis and also CRL and YSD (Table 4) . Thus the influence of added rPL-I on embryonic DNA synthesis and CRL was evident only after the reduction of PRL. However, the influence of rPL-I on yolk sac development was still evident in the presence of PRL (Table 3 ). The influence of PRL on embryonic growth was further investigated by neutralizing the rPRL in the culture medium using anti-rPRL antibodies and simultaneously adding human PRL. The addition of human PRL significantly increased (P<0·05) embryonic DNA synthesis and CRL (Table 5) .
Discussion
The growth and development of the mammalian embryo/ fetus is greatly influenced by hormones secreted by the anterior pituitary, placenta, ovary and uterus. PRL, produced by the anterior pituitary, directly stimulates the development of the mammary glands and secretion of milk (Thordarson & Talamantes 1987 , Forsyth 1988 ) and maintains the functioning of the corpus luteum (Morishige & Rothchild 1974) . In the rat, production of pituitary PRL is not required after day 7 of gestation (Morishige & Rothchild 1974) as embryos grow normally after surgical removal of the anterior pituitary (Pencharz & Long 1931) . Termination of the secretion of pituitary PRL coincides with the peak of PL-I (Tonkowicz et al. 1983 ). In the rat, the peaks of rPL-I and rPL-II production occur between Control Ig=addition of 2 mg/ml non-immune rabbit Ig; anti-rPL-I Ig=2 mg/ml; rPL-I=1 g/ml. gestational days 9 and 13 and 13 and term respectively (Friesen et al. 1993) . The peak of rPL-I production coincides with the period of rapid cellular/tissue differentiation and organogenesis of the embryo. Preservation of the EPC, the early placenta in embryos explanted on day 9 of gestation, is essential for optimal growth and development of the cultured rat embryo. In our study, both rPL-I and rPL-II were produced by the EPC of the embryo and accumulated in the culture medium in concentrations remarkably similar to blood hormone levels in day 11 pregnant rats (Robertson & Friesen 1981) . Removal of the EPC from the embryo eliminated the production of rPL-I and rPL-II. Removal of the EPC in cultured whole rat embryos resulted in reduced embryonic viability and retarded growth because embryonic DNA synthesis, CRL and YSD were compromised. Owing to the dorsiflex pattern of many of the embryos cultured in the absence of EPC, the accuracy of CRL measurement may have been compromised. However, retarded embryo growth was confirmed by DNA synthesis measurement. Indeed DNA synthesis is a more sensitive and accurate assay of embryonic growth in Figure 1 Rat embryos explanted on day 9 of gestation and cultured for 48 h with or without EPC and rPL-I 1 g/ml. E, embryo; YS, yolk sac. In the absence of EPC, YSD in rPL-I-treated embryos was significantly and visibly larger than in untreated embryos. The embryo cultured in the absence of rPL-I was dorsiflexed. 
Group

NRS (n=8)
3·3 0·07 3·2 0·25 3·8 0·07 2·7 0·14 Anti-rPRL (n=19) 3·0 0·07* † 2·7 0·18* † 3·7 0·07 † 2·8 0·21 † Anti-rPRL+rPL-I (n=20) 3·2 0·02 3·3 0·13 4·2 0·04* 3·8 0·16*
The volume of normal rabbit serum (NRS) and rabbit anti-rat prolactin serum (anti-rPRL) used was 100 l per culture; rPL-I was used at 1 g/ml. *Significantly different from NRS group (P<0·05). †Significantly different from anti-rPRL+rPL-I group (P<0·05).
culture than CRL. The addition of exogenous rPL-I increased YSD and yolk sac DNA synthesis, but there was no change in embryonic DNA synthesis and CRL with rPL-I addition alone. Dorsiflexion appeared to be corrected by the addition of rPL-I in many embryos, although this parameter was not studied systematically and quantitatively. Clearly, dorsiflexion was the consequence of aberrant organogenesis in the absence of placental hormones. The embryo culture medium contained an estimated 44 ng/ml rPRL derived from the adult male rat serum (75% v/v). Thus this rPRL may have masked the effect of rPL-I on embryo growth. When the rPRL was neutralized in the culture medium with anti-rPRL serum, the addition of rPL-I significantly increased not only yolk sac DNA synthesis and YSD, but also embryonic DNA synthesis and CRL. The presence of rPRL in the culture medium appeared to partially maintain embryo growth. Indeed, human PRL can substitute for rPRL in this regard. The influence of rPL-I on embryos was evident only when rPRL in the culture medium was neutralized with antibodies. The influence of rPL-I on yolk sac development, however, was still evident even in the presence of rPRL. Indeed, the present demonstration of the effect of PRL on whole rat embryo growth corroborates the finding of Karabulut & Pratten (1998) that PRL from several species significantly increased whole rat embryo growth and development. Our study demonstrates that rPL-I can influence embryonic growth and development. However, it is clear that rPL-I alone was not able to mimic the effect of an intact ectoplacenta, indicating that placental factors other than rPL-I are required for optimal development of the early embryo. While rPL-I is produced only in the first half of pregnancy, rPL-II is the logical candidate to replace rPL-I to influence fetal development during the second half of gestation. The mechanisms by which rPLs influence embryo growth and development remain to be studied. Nevertheless, they are found in the fetal circulation (Orgen & Talamantes 1988 , Freemark et al. 1993 and bind to receptors in fetal tissues (Freemark et al. 1993) . Recent studies of PRL receptor expression in the developing mouse (Tzeng & Linzer 1997) and rat (Royster et al. 1995 , Freemark et al. 1996 embryo have shown that the receptor mRNA and protein are widespread throughout the fetus, including the rat yolk sac. The pattern of expression of PRL receptor in the fetal rodent led the authors to suggest an important role for the PLs, the major ligands for fetal PRL receptors in fetal growth and development. Studies of the ontogenesis of PRL receptors in the human fetus in early gestation led to the same conclusion (Freemark et al. 1997) .
The application of the whole rat embryo culture technique has allowed us to demonstrate for the first time a direct effect of PLs on the early development of the mammalian embryo. This methodology will continue to be useful for gaining further insights into the role of other placental hormones and growth factors in early fetal development. However, it will not lend itself to the study of embryos at later stages of development because, after 2-3 days in culture, the embryos have reached their maximum size for efficient transfer of nutrients and oxygen. Nevertheless, our study has provided the impetus for future studies, for example, to create PL null mutations in mice, in order to address fully the biological significance of PLs in fetal development and maternal functions. The volume of normal rabbit serum (NRS) and rabbit anti-rPRL used was 100 l per culture, and hPRL was used at 1 g/ml. *Significantly different from NRS group (P<0·05). †Significantly different from anti-rPTL+hPRL group (P<0·05).
